Multi‐target‐directed ligands (MTDLs) are compounds designed to concurrently modulate the processes of Aβ aggregation, tau phosphorylation, generation of oxidative stress, inflammation, and synaptic dysfunction, all of which are biological targets associated with AD pathogenesis. This evidence concerns the gene MAPT and Alzheimer disease.